Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2025-12-25 @ 11:35 PM
NCT ID:
NCT05878093
Pre Assignment Details:
A total of 63 participants were randomized in a 1:1 ratio to receive either matching placebo or dupilumab. Randomization was stratified by screening blood eosinophil count (\>=300 cells per cubic millimeter \[/mm\^3\] or \<300 cells/mm\^3).
Recruitment Details:
The study was conducted at 18 centers in China. A total of 151 participants were screened from 16 May 2023 to 27 February 2024, of which 88 were screen failures. Screen failures were mainly due to not meeting the eligibility criteria.
Study:
NCT05878093
Study Brief:
Results Section:
NCT05878093